Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) affects
roughly half the HIV-positive population. The symptoms of cognitive slowing, poor …

HIV-associated neurocognitive disorders (HAND) continue to affect a large proportion of
persons living with HIV despite effective viral suppression with combined antiretroviral …

OBJECTIVE: The apolipoprotein E (APOE) ε4 allele may accelerate the progression of HIV
disease, and increase the risk for developing HIV-associated neurocognitive disorder …

Purpose Survivors of childhood acute lymphoblastic leukemia (ALL) are at increased risk for
neurocognitive problems, with significant interindividual variability in outcome. This study …

Neurocognitive impairments associated with human immunodeficiency virus (HIV) infection
remain a considerable health issue for almost half the people living with HIV, despite …

The goal of the present investigation is to identify the differentially expressed genes (DEGs)
between SARS-CoV-2 infected and normal control samples to investigate the molecular …

NeuroAIDS is a disease that incorporates both infectious and degenerative
pathophysiologic pathways. It has a known cause, has several animal models, and is under …

Human immunodeficiency virus (HIV) enters the brain early after infecting humans and may
remain in the central nervous system despite successful antiretroviral treatment. Many …

Objective: We aimed to evaluate the combined effects of HIV and APOE ε4 allele (s) on glial
metabolite levels, and on known cognitive deficits associated with either condition, across …

This is a cross-sectional, observational study to evaluate the hypothesis that HIV-
seropositive (HIV+) apolipoprotein E4 (APOE4) carriers are at increased risk for HIV …